₹2,254.45-52.20 (-2.26%)
13-Dec-2024₹2,254.00-50.10 (-2.17%)
13-Dec-2024BSE : 500660
NSE : GLAXO
Sector : Health care
ISIN Code : INE159A01016
Last Updated: 13-Dec-2024
Market Cap (₹ Cr) | 38,193 |
Traded Value (₹ Cr) | 0.77 |
Volume (Shares) | 3,421 |
Face Value (₹) | 10 |
52-Week High (₹) | 3,087.95 |
52-Week High Date | 22-Aug-2024 |
52-Week Low (₹) | 1,668.20 |
52-Week Low Date | 21-Dec-2023 |
All Time High (₹) | 3,087.95 |
All Time High Date | 22-Aug-2024 |
All Time Low (₹) | 12.88 |
All Time Low Date | 19-Aug-1988 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 38,185 |
EPS - TTM (₹) [C] | 47.33 |
P/E Ratio (X) [C] | 47.62 |
Face Value (₹) | 10 |
Latest Dividend (%) | 120.00 |
Latest Dividend Date | 07-Nov-2024 |
Dividend Yield (%) | 1.42 |
Book Value Share (₹) [C] | 98.74 |
P/B Ratio (₹) [C] | 22.83 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Kotak Equity Opportunities (G) | 268.88 | 11,00,000 | 1.05 |
Kotak Equity Opportunities (IDCW) | 268.88 | 11,00,000 | 1.05 |
Kotak Equity Opportunities - Direct (G) | 268.88 | 11,00,000 | 1.05 |
Kotak Equity Opportunities - Direct (IDCW) | 268.88 | 11,00,000 | 1.05 |
Aditya Birla SL ELSS Tax Saver Fund (IDCW) | 226.92 | 9,28,316 | 1.44 |
Aditya Birla SL ELSS Tax Saver Fund (G) | 226.92 | 9,28,316 | 1.44 |
Aditya Birla SL ELSS Tax Saver Fund - Direct (IDCW) | 226.92 | 9,28,316 | 1.44 |
Aditya Birla SL ELSS Tax Saver Fund - Direct (G) | 226.92 | 9,28,316 | 1.44 |
SBI Magnum Midcap Fund (G) | 223.78 | 9,15,489 | 1.04 |
SBI Magnum Midcap Fund (IDCW) | 223.78 | 9,15,489 | 1.04 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High (₹) | 2,250.30 2,313.05 |
Week Low/High (₹) | 2,250.30 2,399.00 |
Month Low/High (₹) | 2,250.30 2,540.00 |
Year Low/High (₹) | 1,667.85 3,088.00 |
All time Low/High (₹) | 12.88 3,088.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -3.94% | -3.80% | 0.52 | 0.37% |
1 Month | -8.13% | -8.10% | 5.72 | 5.13% |
3 Month | -22.36% | -22.41% | -0.91 | -2.32% |
6 Month | -16.49% | -16.54% | 6.93 | 5.85% |
1 Year | 29.96% | 30.07% | 18.03 | 18.36% |
3 Year | 21.12% | 21.09% | 40.92 | 42.61% |
Independent Director : D Sundaram
Company Sec. & Compli. Officer : A A Nadkarni
Independent Director : P V Bhide
Independent Director : A N Roy
Non Executive Director : Subesh Williams
Chairperson : Renu S Karnad
Independent Director : Sunita Maheshwari
Independent Director : Manu Anand
Managing Director : Bhushan Akshikar
Whole Time Director & CFO : J. Chandy
Registered Office: GSK House, Dr Annie Besant Road Worli,Mumbai,Maharashtra-400030 Ph: 91-022-24959595
1. What's the Glaxosmithkline Pharmaceuticals Ltd share price today?
Glaxosmithkline Pharmaceuticals Ltd share price was Rs 2,254.45 at close on 13th Dec 2024. Glaxosmithkline Pharmaceuticals Ltd share price was down by 2.26% from the previous closing price of Rs 2,306.65. Glaxosmithkline Pharmaceuticals Ltd share price trend:
2. How can I quickly analyse the performance of the Glaxosmithkline Pharmaceuticals Ltd stock?
The performance of the Glaxosmithkline Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Glaxosmithkline Pharmaceuticals Ltd?
Glaxosmithkline Pharmaceuticals Ltd has a market capitalisation of Rs 38,193 crore.
4. What is Glaxosmithkline Pharmaceuticals Ltd's 52-week high/low share price?
The Glaxosmithkline Pharmaceuticals Ltd’s 52-week high share price is Rs 3,087.95 and 52-week low share price is Rs 1,668.20.
5. Is the Glaxosmithkline Pharmaceuticals Ltd profitable?
On a consolidated basis, Glaxosmithkline Pharmaceuticals Ltd reported a profit of Rs 248.69 crore on a total income of Rs 1,036.93 crore for the quarter ended 2024. For the year ended Sep 2024, Glaxosmithkline Pharmaceuticals Ltd had posted a profit of Rs 252.50 crore on a total income of Rs 1,050.00 crore.
6. Which are Glaxosmithkline Pharmaceuticals Ltd’s peers in the Health care sector?
Glaxosmithkline Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Glenmark Pharma., Biocon, Ipca Labs., Glaxosmi. Pharma, Ajanta Pharma, Piramal Pharma, Suven Pharma.
7. Who owns how much in Glaxosmithkline Pharmaceuticals Ltd?
Key changes to the Glaxosmithkline Pharmaceuticals Ltd shareholding are as follows: